Sinner, F., Pinter, M., Scheiner, B., Ettrich, T.J., Sturm, N., González-Carmona, M. Á., Waidmann, O., Finkelmeier, F., Himmelsbach, V., Toni, E. de, Ben Khaled, N., Mohr, R., Fründt, T.W., Kütting, F., Bömmel, F. van, Lieb, S., Krug, S., Bettinger, D., Schultheiß, M., Jochheim, L.S., Best, J., Müller, C., Keitel-Anselmino, V. und Venerito, M. (2022) Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience [cd]. Freiburg: Universität. doi:10.3390/cancers14235966.

Sinner, Friedrich, Matthias Pinter, Bernhard Scheiner, Thomas J. Ettrich, Niklas Sturm, María Á. González-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico de Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Bömmel, Sabine Lieb, Sebastian Krug, Dominik Bettinger, Michael Schultheiß, Leonie S. Jochheim, Jan Best, Christian Müller, Verena Keitel-Anselmino, und Marino Venerito. Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience. Cd. Freiburg: Universität, [2022?], Freiburg: Universität, [2022?]. https://doi.org/10.3390/cancers14235966.

Sinner, F., Pinter, M., Scheiner, B., Ettrich, T. J., Sturm, N., González-Carmona, M. Á., Waidmann, O., Finkelmeier, F., Himmelsbach, V., Toni, E. de, Ben Khaled, N., Mohr, R., Fründt, T. W., Kütting, F., Bömmel, F. van, Lieb, S., Krug, S., Bettinger, D., Schultheiß, M., Jochheim, L. S., Best, J., Müller, C., Keitel-Anselmino, V., & Venerito, M. (ca. 2022). Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience [Cd]. Universität. https://doi.org/10.3390/cancers14235966

Sinner, F., M. Pinter, B. Scheiner, T. J. Ettrich, N. Sturm, M. Á. González-Carmona, O. Waidmann, F. Finkelmeier, V. Himmelsbach, E. de Toni, N. Ben Khaled, R. Mohr, T. W. Fründt, F. Kütting, F. van Bömmel, S. Lieb, S. Krug, D. Bettinger, M. Schultheiß, L. S. Jochheim, J. Best, C. Müller, V. Keitel-Anselmino, und M. Venerito. Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience. cd, Universität, 2022, https://doi.org/10.3390/cancers14235966.

SINNER, Friedrich, Matthias PINTER, Bernhard SCHEINER, Thomas J. ETTRICH, Niklas STURM, María Á. GONZÁLEZ-CARMONA, Oliver WAIDMANN, Fabian FINKELMEIER, Vera HIMMELSBACH, Enrico de TONI, Najib BEN KHALED, Raphael MOHR, Thorben Wilhelm FRÜNDT, Fabian KÜTTING, Florian van BÖMMEL, Sabine LIEB, Sebastian KRUG, Dominik BETTINGER, Michael SCHULTHEISS, Leonie S. JOCHHEIM, Jan BEST, Christian MÜLLER, Verena KEITEL-ANSELMINO und Marino VENERITO, 2022. Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience. Freiburg: Universität